P

resident Trump says drug makers are “getting away with murder” — and these days, there are few companies that better embody his frustrations than Celgene.

The drug maker keeps lots of cash overseas. It does some of its manufacturing abroad. Three times this year, it’s hiked the price of its best-selling cancer drug. And the man presiding over the company, Bob Hugin, donates lots of money to “political people,” which Trump has blasted as a bald attempt to curry favor with the establishment. (Though, inconveniently, Hugin has also donated to Trump himself.)

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • http://alph.st/b66333fb I think the 11% hike in Celgene’s product sales in the recent quarter is mainly because of the increase in their drug prices. Remember, on October 19th, Celgene had increased prices of Revlimid and Pomalyst drugs.

  • Are we still pretending that something Trump says has any meaning or purpose other than serving himself?
    He is like a used car dealer, if you like it red, he likes it red too, if you rant against imported cars he will too, and viceversa and so on.
    publicly despising pharmas to please voters and media. Being cozy and sweet while playing golf with pharma execs (as long as they let him win)

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy